Grufity logoGrufity logo

Phreesia, Inc. Stock Research

PHR

32.29USD+1.44(+4.67%)Market Closed

Market Summary

USD32.29+1.44
Market Closed
4.67%

PHR Stock Price

PHR RSI Chart

PHR Valuation

Market Cap

1.7B

Price/Earnings (Trailing)

-9.2

Price/Sales (Trailing)

6.47

EV/EBITDA

-9.08

Price/Free Cashflow

-14.39

PHR Price/Sales (Trailing)

PHR Profitability

EBT Margin

-70.27%

Return on Equity

-57.62%

Return on Assets

-46.46%

Free Cashflow Yield

-6.95%

PHR Fundamentals

PHR Revenue

Revenue (TTM)

262.3M

Revenue Y/Y

30.74%

Revenue Q/Q

7.72%

PHR Earnings

Earnings (TTM)

-184.6M

Earnings Y/Y

-10.52%

Earnings Q/Q

14.02%

Price Action

52 Week Range

13.1940.00
(Low)(High)

Last 7 days

2.5%

Last 30 days

-12.0%

Last 90 days

-0.2%

Trailing 12 Months

22.5%

PHR Financial Health

Current Ratio

3.94

Debt/Equity

0.01

Debt/Cashflow

-29.79

PHR Investor Care

Shares Dilution (1Y)

3.11%

Diluted EPS (TTM)

-3.57

Peers (Alternatives to Phreesia)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
441.4B
324.2B
-0.20% -6.09%
21.94
1.36
12.71% 16.40%
28.6B
2.1B
10.63% -13.49%
72.07
13.75
17.88% -8.53%
27.9B
-
0.98% 20.75%
47.36
4.81
- -
MID-CAP
9.0B
3.5B
11.88% 31.28%
-116.8
2.57
7.15% -34.72%
4.2B
2.4B
0.08% -64.09%
-0.31
1.75
18.41% -3085.58%
2.6B
1.3B
2.68% -54.69%
464.82
2.03
14.48% -92.74%
SMALL-CAP
1.7B
262.3M
-11.99% 22.50%
-9.2
6.47
33.16% -131.28%
1.4B
837.2M
-9.94% -42.05%
23.52
1.7
3.88% -92.18%
1.1B
625.9M
-3.12% -16.74%
50.13
1.84
6.21% 3223.77%
892.6M
53.5M
14.82% -13.81%
83.4
16.7
10.94% 3.61%
828.7M
266.8M
6.53% 36.04%
68.54
3.11
3.94% 106.86%
810.3M
2.8B
-16.25% 3.00%
4.3
0.29
67.39% 42.77%
644.9M
276.2M
-18.51% -55.34%
-4.69
2.33
14.18% 10.32%
267.2M
63.1M
-19.22% -61.20%
-25.47
4.23
9.93% -1043.45%
151.4M
357.1M
-7.60% -2.95%
-1.09
0.42
33.22% -57.66%

Financials for Phreesia

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue7.0%262,344,000245,156,000228,296,000213,233,000197,021,000
  S&GA Expenses3.1%152,209,000147,614,000131,440,000106,421,00082,174,000
  R&D Expenses9.7%83,341,00075,945,00064,846,00052,265,00041,125,000
EBITDA-1.4%-164,403,000-162,125,000-140,247,000--
EBITDA Margin5.2%-0.63-0.66-0.61--
Earnings Before Taxes-2.1%-184,355,000-180,559,000-158,161,000-117,979,000-79,513,000
EBT Margin4.6%-0.70-0.74-0.69--
Interest Expenses30.3%-856,000-1,228,000-1,229,000-1,084,000-1,123,000
Net Income-2.1%-184,576,000-180,752,000-158,429,000-118,161,000-79,806,000
Net Income Margin4.6%-0.70-0.74-0.69--
Free Cahsflow10.6%-118,055,000-132,008,000-119,092,000--
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-6.7%397426459494529
  Current Assets-9.4%287316349386464
    Cash Equivalents-12.9%210241269314400
  Goodwill0%34.0034.0034.0034.008.00
Liabilities-0.7%77.0078.0078.0077.0071.00
  Current Liabilities1.1%73.0072.0071.0068.0065.00
  Long Term Debt-23.7%4.005.006.007.005.00
Shareholder's Equity-8.1%320348381417458
  Retained Earnings-7.6%-568-527-481-429-383
  Additional Paid-In Capital1.7%912896881861849
Shares Outstanding0.5%53.0052.0052.0051.00-
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations3.3%-112-115-102-74.71-32.65
  Share Based Compensation3.6%54.0052.0045.0036.0030.00
Cashflow From Investing11.4%-60.27-68.05-65.35-65.23-38.54
Cashflow From Financing-21.5%-18.33-15.09-13.27235217

Risks for PHR

What is the probability of a big loss on PHR?

82.0%


Probability that Phreesia stock will be more than 20% underwater in next one year

81.0%


Probability that Phreesia stock will be more than 30% underwater in next one year.

76.4%


Probability that Phreesia stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PHR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Phreesia was unfortunately bought at previous high price.

Drawdowns

Returns for PHR

Cumulative Returns on PHR

15.4%


3-Year Cumulative Returns

Which funds bought or sold PHR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-23
MetLife Investment Management, LLC
unchanged
-
183,778
864,400
0.01%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-1.37
29,000
144,000
-%
2023-02-28
Voya Investment Management LLC
reduced
-85.16
-2,921,480
678,524
-%
2023-02-24
SRS Capital Advisors, Inc.
unchanged
-
391
1,391
-%
2023-02-21
MACQUARIE GROUP LTD
reduced
-32.61
-350,000
1,918,000
-%
2023-02-15
Jasper Ridge Partners, L.P.
unchanged
-
143,803
674,803
0.04%
2023-02-15
LAZARD ASSET MANAGEMENT LLC
reduced
-43.43
-3,437,000
8,771,000
0.01%
2023-02-15
JANE STREET GROUP, LLC
reduced
-6.43
55,951
352,951
-%
2023-02-15
Capital Impact Advisors, LLC
added
4.17
200,038
688,038
0.67%
2023-02-15
PFS INVESTMENTS INC.
new
-
212,000
212,000
-%

1–10 of 48

Latest Funds Activity

Are funds buying PHR calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own PHR
No. of Funds

Phreesia News

Defense World

Brokers Set Expectations for Phreesia, Inc.'s Q1 2024 Earnings ....

Defense World,
25 hours ago

Schedule 13G FIlings of Phreesia

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
t. rowe price investment management, inc.
5.1%
2,676,879
SC 13G
Feb 14, 2023
price t rowe associates inc /md/
0.3%
180,384
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
brown advisory inc
5.8%
3,068,782
SC 13G
Feb 09, 2023
vanguard group inc
7.34%
3,872,425
SC 13G/A
Jan 25, 2023
blackrock inc.
8.7%
4,564,585
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
15.2%
7,797,879
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 07, 2022
blackrock inc.
11.7%
6,010,340
SC 13G/A
May 10, 2021
price t rowe associates inc /md/
10.7%
5,402,206
SC 13G/A

PHR Fair Value

Phreesia fair value in different scenarios

The table shows the Fair Value estimates for Phreesia for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

2.46

-92.38%

3.60

-88.85%

7.20

-77.70%

11.86

-63.27%

16.25

-49.67%
Current Inflation

2.38

-92.63%

3.39

-89.50%

6.50

-79.87%

10.46

-67.61%

14.19

-56.05%
Very High Inflation

2.27

-92.97%

3.12

-90.34%

5.66

-82.47%

8.84

-72.62%

11.81

-63.43%

Historical Phreesia Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Phreesia

View All Filings
Date Filed Form Type Document
Mar 28, 2023
3
Insider Trading
Mar 28, 2023
3
Insider Trading
Mar 28, 2023
4
Insider Trading
Mar 23, 2023
10-K
Annual Report
Mar 23, 2023
4/A
Insider Trading
Mar 23, 2023
S-8
Employee Benefits Plan
Mar 22, 2023
8-K
Current Report
Mar 22, 2023
8-K
Current Report
Mar 20, 2023
4
Insider Trading
Feb 14, 2023
SC 13G
Major Ownership Report

Latest Insider Trading transactions for PHR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-24
Gandhi Balaji
acquired
-
-
21,428
chief financial officer
2023-03-17
Linetsky David
sold (taxes)
-605
33.65
-18.00
svp, life sciences
2023-03-16
Linetsky David
sold (taxes)
-6,683
34.81
-192
svp, life sciences
2023-03-15
Linetsky David
sold (taxes)
-879
33.84
-26.00
svp, life sciences
2023-02-02
Rasmussen Randy
sold
-190,600
40.00
-4,765
chief financial officer
2023-02-02
VanDuyn Amy Beth
sold
-12,000
40.00
-300
svp, human resources
2023-02-02
Linetsky David
sold
-449,989
39.549
-11,378
svp, life sciences
2023-02-02
Davidoff Michael J.
sold
-294,564
39.2073
-7,513
svp, payer business
2023-01-31
Davidoff Michael J.
sold
-124,082
38.0037
-3,265
svp, payer business
2023-01-31
Munson Gillian
acquired
9,972
37.49
266
-

1–10 of 50

Chaim Indig
1700
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.

PHR Income Statement

2023-01-31
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Revenue:   
Total revenue$ 280,910$ 213,233$ 148,677
Expenses:   
Cost of revenue (excluding depreciation and amortization)58,94442,66923,461
Payment processing expense50,32338,71928,925
Sales and marketing151,263106,42142,972
Research and development91,24452,26522,622
General and administrative80,38468,67440,460
Depreciation17,98814,9859,770
Amortization7,3166,3176,138
Total expenses457,462330,050174,348
Operating loss(176,552)(116,817)(25,671)
Other (expense) income, net(175)(78)1
Interest income (expense), net1,064(1,084)(1,573)
Total other income (expense), net889(1,162)(1,572)
Loss before provision for income taxes(175,663)(117,979)(27,243)
Provision for income taxes(483)(182)(49)
Net loss$ (176,146)$ (118,161)$ (27,292)
Net loss per share attributable to common stockholders - basic (in dollars per share)$ (3.36)$ (2.37)$ (0.69)
Net loss per share attributable to common stockholders - diluted (in dollars per share)$ (3.36)$ (2.37)$ (0.69)
Weighted-average common shares outstanding - basic (in shares)52,440,06749,888,43639,519,640
Weighted-average common shares outstanding - diluted (in shares)52,440,06749,888,43639,519,640
Subscription and related services   
Revenue:   
Total revenue$ 128,975$ 95,514$ 69,042
Payment processing fees   
Revenue:   
Total revenue78,36865,20149,900
Network solutions   
Revenue:   
Total revenue$ 73,567$ 52,518$ 29,735

PHR Balance Sheet

2023-01-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Current:  
Cash and cash equivalents$ 176,683$ 313,812
Settlement assets22,59919,590
Accounts receivable, net of allowance for doubtful accounts of $1,053 and $863 as of January 31, 2023 and 2022, respectively51,39440,262
Deferred contract acquisition costs1,0561,642
Prepaid expenses and other current assets10,70911,043
Total current assets262,441386,349
Property and equipment, net of accumulated depreciation and amortization of $59,847 and $53,321 as of January 31, 2023 and 2022, respectively21,67034,645
Capitalized internal-use software, net of accumulated amortization of $37,236 and $31,139 as of January 31, 2023 and 2022, respectively35,15017,643
Operating lease right-of-use assets5692,337
Deferred contract acquisition costs1,7542,437
Intangible assets, net of accumulated amortization of $2,549 and $1,178 as of January 31, 2023 and 2022, respectively11,40112,772
Deferred tax asset81515
Goodwill33,73633,621
Other assets3,2554,157
Total Assets370,057494,476
Current:  
Settlement obligations22,59919,590
Current portion of finance lease liabilities and other debt5,1725,821
Current portion of operating lease liabilities9341,281
Accounts payable10,8365,119
Accrued expenses21,81020,128
Deferred revenue17,68816,493
Total current liabilities79,03968,432
Long-term finance lease liabilities and other debt2,7257,423
Operating lease liabilities, non-current3491,276
Long-term deferred revenue12565
Total Liabilities82,23877,196
Commitments and contingencies (Note 11)
Stockholders’ Equity:  
Common stock, $0.01 par value—500,000,000 shares authorized as of both January 31, 2023 and 2022; 54,187,172 and 52,095,964 shares issued as of January 31, 2023 and 2022, respectively542521
Additional paid-in capital926,957860,657
Accumulated deficit(606,084)(429,938)
Treasury stock, at cost, 971,236 and 301,003 shares as of January 31, 2023 and 2022, respectively(33,596)(13,960)
Total Stockholders’ Equity287,819417,280
Total Liabilities and Stockholders’ Equity$ 370,057$ 494,476